21,554 Shares in Roche Holding AG (OTCMKTS:RHHBY) Bought by Minot DeBlois Advisors LLC

Minot DeBlois Advisors LLC purchased a new stake in Roche Holding AG (OTCMKTS:RHHBY - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 21,554 shares of the company's stock, valued at approximately $752,000.

Several other institutional investors and hedge funds have also recently modified their holdings of RHHBY. Altrius Capital Management Inc boosted its position in shares of Roche by 0.3% during the fourth quarter. Altrius Capital Management Inc now owns 183,448 shares of the company's stock valued at $6,399,000 after purchasing an additional 603 shares in the last quarter. Hantz Financial Services Inc. raised its stake in shares of Roche by 0.9% in the fourth quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company's stock worth $1,176,000 after purchasing an additional 305 shares during the last quarter. Hancock Whitney Corp raised its stake in shares of Roche by 6.8% in the fourth quarter. Hancock Whitney Corp now owns 23,516 shares of the company's stock worth $820,000 after purchasing an additional 1,496 shares during the last quarter. SVB Wealth LLC purchased a new stake in Roche during the fourth quarter valued at $555,000. Finally, HighPoint Advisor Group LLC grew its stake in shares of Roche by 2.8% during the 4th quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company's stock valued at $387,000 after acquiring an additional 304 shares during the period.

Wall Street Analyst Weigh In

Several research firms recently issued reports on RHHBY. HSBC cut Roche from a "buy" rating to a "hold" rating in a research report on Monday, April 28th. Sanford C. Bernstein raised Roche to a "strong-buy" rating in a research note on Thursday, January 30th. UBS Group raised Roche from a "hold" rating to a "strong-buy" rating in a research note on Thursday, February 13th. Morgan Stanley started coverage on Roche in a research note on Wednesday, February 12th. They issued an "equal weight" rating for the company. Finally, Hsbc Global Res lowered Roche from a "strong-buy" rating to a "hold" rating in a research note on Monday, April 28th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating, one has given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold".

Roche Price Performance

RHHBY traded up $0.63 during trading on Friday, hitting $39.03. 1,891,819 shares of the stock were exchanged, compared to its average volume of 2,997,473. The firm has a 50 day simple moving average of $40.04 and a 200 day simple moving average of $38.59. Roche Holding AG has a 1 year low of $31.19 and a 1 year high of $44.31. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.86.

Roche Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.